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Abstract: New group 11 metal complexes have been prepared using the previously 
described tripodal bis(imidazole) thioether ligand (N-methyl-4,5-diphenyl-2-
imidazolyl)2C(OMe)C(CH3)2S(tert-Bu) ({BITOMe,StBu}, 2). The pincer ligand offers a N2S 
donor atom set that can be used to coordinate the group 11 metals in different  
oxidation states [AuI, AuIII, AgI, CuI and CuII]. Thus the new compounds 
[Au{BITOMe,StBu}Cl][AuCl4]2 (3), [Au{BITOMe,StBu}Cl] (4), [Ag{BITOMe,StBu}X] (X = 
OSO2CF3- 5, PF6- 6) and [Cu{BITOMe,StBu}Cl2] (7) have been synthesized from reaction of 
2 with the appropriate metal precursors, and characterized in solution. While attempting 
characterization in the solid state of 3, single crystals of the neutral dinuclear mixed AuIII-
AuI species [Au2{BITOMe,S}Cl3] (8) were obtained and its crystal structure was determined 
by X-ray diffraction studies. The structure shows a AuIII center coordinated to the pincer 
ligand through one N and the S atom. The soft AuI center coordinates to the ligand  
through the same S atom that has lost the tert-butyl group, thus becoming a thiolate ligand. 
The short distance between the AuI-AuIII atoms (3.383 Å) may indicate a weak  
metal-metal interaction. Complexes 2-7 and the previously described CuI compound 
[Cu{BITOMe,StBu}]PF6 (9) have been evaluated in the oxidation of biphenyl ethylene with 
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tert-butyl hydrogen peroxide (TBHP) as the oxidant. Results have shown that the AuI and 
AgI complexes 4 and 6 (at 10 mol % loading) are the more active catalysts in this oxidative 
cleavage. The antimicrobial activity of compounds 2-5, 7 and 9 against Gram-positive and 
Gram-negative bacteria and yeast has also been evaluated. The new gold and silver 
compounds display moderate to high antibacterial activity, while the copper derivatives are 
mostly inactive. The gold and silver complexes were also potent against fungi. Their 
cytotoxic properties have been analyzed in vitro utilizing HeLa human cervical carcinoma 
cells. The compounds displayed a very low cytotoxicity on this cell line (5 to 10 times 
lower than cisplatin) and on normal primary cells derived from C57B6 mouse muscle 
explants, which may make them promising candidates as potential antimicrobial agents and 
safer catalysts due to low toxicity in human and other mammalian tissues. 
Keywords: tripodal bis(imidazol) thioether pincer ligands; group 11 metals; oxidation 
alkenes; antimicrobial; non-toxic 
 
1. Introduction 
In the last few years the use of mixed-donor pincer ligands has increased due to the catalytic 
potential of their metal complexes in different organic transformations [1]. They are important in 
homogenous catalysis since they provide stabilization and temporary coordinative saturation to the 
metal center via chelation until an active site is required. A large number of donor ligands with many 
donor type permutations (C, O, S, N, P, etc…), charge and coordination number have been  
described [2]. Among these various combinations, mixed-donor ligands of the type N,S are particularly 
interesting. They are currently used as modeling active sites for metalloenzymes [3] and they have 
found applications in homogeneous catalysis [4] and medicinal chemistry (brain-imaging [5], 
antimicrobial properties [6]). They display a hard donor (N) and a soft donor (S) atom that can 
coordinate to a wide range of metals. They can bind to the same metal in a particular coordination state 
providing a different bond strength and lability for each donor atom. There is also a current interest in 
the incorporation of these N,S donor atoms (usually the ligands contain combinations of thiolato or 
thioether functional groups and amines, pyrazolyl or imidazole groups) in macrocycles [7] and in 
polydentate and tripodal ligands [3-6,8] in order to probe the biologically relevant coordination 
chemistry, the supramolecular chemistry (and metal ion recognition), or the catalytic reactions of 
different metals. 
Recently, biomimetic tripodal bis(imidazole)thioether (BIT) ligands have been reported by  
Nicholas et al. incorporating biologically most relevant N-imidazole groups which display a 
significantly different basicity and donor-acceptor properties with respect to the other common 
nitrogen ligands (such as amines and pyrazolyl ligands) [9-11]. These ligands provide a sterically 
encumbered environment that could prevent, in principle, the formation of bimetallic species.  
In the search for copper complexes that accurately mimic the electronic and features of the CuM site 
of copper hydroxylase enzymes, compounds of CuI have been successfully synthesized with these 
tripodal BIT ligands (Scheme 1) [9-11]. Their reactivity towards dioxygen was studied and new 




dimeric hydroxo-copper(II) derivatives were obtained. In order to incorporate the ligand set of the 
CuM site of the copper hydroxylase enzymes, the BIT ligands were modified according to the 
imidazole C(Ph or H) and N(H or Me) substituents as well as the positions (2- or 4-) of the tripodal 
attachment [11]. The authors concluded that N-Me substitution and 4-tethering on the imidazole unit 
increased oxidation and oxygenation reactivity on the derived CuI complexes while Ph-substitution and 
2-tethering decreased reactivity [11]. 
Scheme 1. Preparation of new gold, silver and copper complexes (3-7) and previously 
described copper(I) 9 [10] incorporating the pincer BITOMe,StBu ligand 2 [10]. 
 
We thought that some of these tripodal ligands (specifically BITOR,SR’) could be useful in the 
synthesis of group 11 metal complexes with the metals in different oxidation states. We wanted a 
chelating (pincer) system able to stabilize group 11 metal derivatives, but with basicity and electronic 
properties different from those of amines. We were especially interested in the preparation of gold 
complexes in different oxidation states (I and III) with the same set of ligands (or same set of mixed-
donor atoms within the ligand) to study their catalytic (oxidation reactions) and biological (cytotoxic, 
antimicrobial) behavior as a function of the oxidation state of the gold center. We also wanted to study 




the activity of different metals from the same triad with the same ligand. We report here on  
the preparation and characterization of group 11 metal complexes with previously described 
potentially pincer tripodal bis(imidazole) thioether ligand (N-methyl-4,5-diphenyl-2-
imidazolyl)2C(OMe)C(CH3)2S(tert-Bu) {BITOMe,StBu} 2. Thus, new compounds 
[Au{BITOMe,StBu}Cl][AuCl4]2 (3), [Au{BITOMe,StBu}Cl] (4), [Ag{BITOMe,StBu}X] (X = OSO2CF3- 5, PF6- 
6) and [Cu{BITOMe,StBu}Cl2] (7) have been synthesized from reaction of 2 (Scheme 1) with the 
appropriate metal precursors, and characterized in solution. Their catalytic activity in the oxidation of 
biphenyl ethylene with tert-butyl hydrogen peroxide (TBHP) as the oxidant has been studied. AuI and 
especially AgI complexes displayed moderate catalytic activity. The antimicrobial activity of 
compounds 2-5 and 7 and ligand 2 [10] and [Cu{BITOMe,StBu}(NCCH3)]PF6 (9) [10] were tested 
against Gram-positive and Gram-negative bacteria and yeast. The cytotoxic properties of these novel 
compounds were analyzed in vitro utilizing HeLa human cervical carcinoma cells. AuI, AuIII and AgI 
derivatives displayed high to moderate antibacterial/antifungal activity, while all the compounds were 
less cytotoxic against the HeLa tumor cells than cisplatin and even less toxic to normal primary cells 
derived from C57B6 mouse muscle explants. 
2. Results and Discussion  
2.1. Chemistry 
BIT ligands with bulkier S-alkyl groups (tert-Bu or CPh3) such as BITOMe,StBu (2) had been 
employed by Nicholas and co-workers in an attempt to inhibit dinuclear Cu complex formation to 
potentially kinetically stabilize mono-Cu-O2 species. However, reactions of the CuI derivatives afford 
mainly dinuclear Cu alkoxo and hydroxo complexes and the oxygenation reactivity of the CuI 
complexes depends markedly on the carbinol and thioether susbtituents [10].  
The oxygenation of CuI complex with ligand BITOH,SMe affords a dinuclear CuII compound featuring 
bridging BIT-alkoxo ligands and terminal –SOMe2. The incorporation of methyl in BITOMe,SR’ ligands 
prevents the oxidation of the sulfur atom. The different R’ substituent affects the reactivity of the CuI 
towards oxygenation and thus sterically hindered ligand BITOMe,StBu (2) affords a slower  
oxygenation [10]. We choose ligand 2 as a candidate for the preparation of different complexes of Au, 
Ag and Cu to be applied in homogeneous oxidation reactions as well as to study their  
biological activity. 
Ligand 2 was prepared as previously reported [10] but we isolated and fully characterized precursor 
ligand BITOH,StBu (1) and prepared 2 from isolated 1 (see the Experimental section). The addition of 
ligand 2 to solutions of different salts of group 11 metals (see Experimental for details) affords 
compounds [Au{BITOMe,StBu}Cl][AuCl4]2 (3), [Au{BITOMe,StBu}Cl] (4), [Ag{BITOMe,StBu}X] (X = 
OSO2CF3- 5, PF6- 6) and [Cu{BITOMe,StBu}Cl2] (7) (Scheme 1). Depending on the metals, 2 acts as a 
pincer ligand (see Scheme 1). All complexes were isolated in moderate yields as air-stable solids. The 
stoichiometry of the compounds is proposed on the basis of their spectroscopic characterization, 
microanalysis, mass spectrometry and conductivity studies (see experimental). The geometries for the 
metal in these derivatives (square-planar for AuIII, linear for AuI and AgI and, based on the X-ray 
structure of related mononuclear [(BITOMe,SMe)CuII(DMF)2]2+ [10] square-pyramidal geometry for the 




Cu(II)) are the most plausible ones considering all these data. It is clear that the two silver compounds 
5 with the triflate ligand and 6 with the PF6- anion are different. Compound 5 is a neutral compound 
with the triflate coordinated as a covalent (instead of ionic) group [12], as confirmed by its IR and 
conductivity measurements (see Experimental). However, polynuclear structures cannot be excluded 
for the silver derivatives. The monomeric nature of the CuII derivative [Cu{BITOMe,StBu}Cl2] (7) was 
confirmed by EPR studies of solutions of 7 in CH3CN at 77 K. The X-band spectrum shows signals 
that can be interpreted as being due to a paramagnetic entity (S ) 1/2) with nearly axial symmetry, 
whose gyromagnetic tensor was determined by g || = 2.35 and g ⊥ = 2.073, and is typical for 
monomeric or isolated CuII complexes [13]. Unfortunately we could not get crystals of enough quality 
for single crystal X-ray diffraction studies of 4-7.  
We obtained high quality red crystals from CH2Cl2/Et2O solutions of the Au(III) compound 
[Au{BITOMe,StBu}Cl][AuCl4]2 (3). The structure corresponds to a new neutral dinuclear Au(III)-Au(I) 
compound (8 in Scheme 1). The structure is shown in Figure 1, while selected bond and angles are 
presented in Table 1. The tripodal ligand is coordinated to both a AuIII center and a AuI center via the 
sulfur atom which has lost the tert-Bu group becoming a thiolato functional group instead of the 
original thioether. The AuIII ion is four-coordinated in a square-planar geometry as expected with 
angles close to 90. The AuI is two-coordinated, but the coordination geometry around the gold atom is 
slightly distorted from linearity, with a S(1)-Au(2)-Cl(3) angle of 174.81(8). The AuIII-Cl bond lengths 
are 2.3066(18) and 2.31119(19) Å, similar to those found for the only two crystal structures of mixed 
Au(III)-Au(I) species with a S atom as a bridge and containing chlorides, [Na(15-crown-
5)]4[AuCl2]2[Au4Cl6S2] (2.34(1)-2.31(1)) and [Na(15-crown-5)] [Au4Cl6S2] (2.332(3)-2.328(3)) [14]. 
The AuIII-S bond length (2.327(2) Å) compares well with the value found for one of the few Au(III) 
thiolate complexes described [Au2Cl4(μ-SPh)2] (2.332(5)-2.339(5) Å) [15] and is shorter than those 
found for mixed AuIII-AuI thiolate complexes with ligands coordinated to the AuIII other than 
chlorides (e.g., [(C6F5)3Au(μ2-2-SC6H4NH2)(AudppmAu)(μ2-2-SC6H4NH2)Au(C6F5)] (2.372(3)-
2.375(5) Å) [16], and 2.380(2) [(C6F5)3Au(μ2-SC6F5)(AudppfAu)( μ2-SC6F5)Au(C6F5)3]) [17]. The 
AuI-S and AuI-Cl distances of 2.248(2) Å and 2.258(2) Å are very close to those found in the above 
mentioned crystal structures of [Na(15-crown-5)]4[AuCl2]2[Au4Cl6S2] (2.24(2) and 2.24(1) Å) and 
[Na(15-crown-5)] [Au4Cl6S2] (2.247(3) and 2.282(2) Å) [14]. 
Figure 1. Molecular drawing of neutral dinuclear mixed AuIII-AuI species 
[Au2{BITOMe,S}Cl3] 8 (obtained while crystallizing compound[Au{BITOMe,StBu}Cl][AuCl4]2 
3) with the atomic numbering scheme. 
 




Table 1. Selected bond distances (Å) and angles (°) in species 8. 
Au1 N1 2.038(5) Å N1 Au1 Cl1 177.4(2)° 
Au1 Cl1 2.3066(18) Å Cl2 Au1 S1 174.35(8)° 
Au1 Cl2 2.3119(19) Å N1 Au1 Cl2 91.01(17)° 
Au1 S1 2.327(2) Å Cl1 Au1 Cl2 90.66(7)° 
Au2 S1 2.248(2) Å  N1 Au1 S1 89.42(17) 
Au2 Cl3 2.258(2) Å Cl1 Au1 S1 89.11(7)° 
Au1 Au2 3.383 Å S1 Au2 Cl3 174.81(8)° 
 Au2 S1 Au1 95.37(6)° 
The AuI-AuIII distance is 3.383 Å and it is comparable to the shortest distances obtained in two 
other bridging thiolate and sulfide mixed AuI-AIII complexes. Thus the AuI-AuIII distances obtained for 
tetranuclear [(C6F5)3Au(μ2-SC6F5)(AudppfAu)(μ2-SC6F5)Au(C6F5)3] are 3.2812(7) and 3.3822(7) Å 
[3.2923(7) and 3.4052(7) Å] [17] and, in the case of [{S(Au2dppf)}2{Au(C6F5)2}][CF3SO3], 3.2923(7) 
and 3.4052(7) Å [18]. The above mentioned distances (including that in 8) are shorter than  
those reported in other sulfide, thiolate, or selenide mixed derivatives [3.404(1)-4.011(1) Å] [17-20]. 
This distance may be indicative of the presence of a weak interaction between the AuI and AuIII 
centers [17] and is similar to that for AuI-AuI contacts in many molecules.  
Although the loss of the tert-Bu group in the [Cu(BITOMe,StBu)] complexes was not described, 
Nicholas et al. [10] reported the loss of the trityl group (CPh3) from [Cu(BITOMe,STr)] derivatives in 
reactions of ligand ((BITOMe,STr) and [Cu(CH3CN)4]PF6 with O2 or under Ar in the presence of  
tert-BuNC. The compounds obtained were [(BITOMe,S)2Cu2(μ-OH)2](PF6)2 in the first case or 
[(BITOMe,S)2Cu2(tBuNC)2] and [(BITOMe,S)Cu2 (tBuNC)2]PF6 in the second [10]. The authors reported 
that the loss of trityl group occured before oxygenation. In our case this cleavage occurs with 
concomitant reduction of one counter ion [AuCl4]- to AuCl, which then coordinates to the S atom. 
Some thioether ligands can afford Au(I) derivatives by reduction of HAuCl4 [21] and the reduction of 
AuIII complexes with calix[4]arenes modified by thioether groups on the upper rim to AuI has been 
reported as well [22]. Carbon-sulfide bond cleavage in spontaneously adsorbed thioether-based 
monolayers at gold was described and gold-bound thiolate species were detected [23]. The nature of 
the N2S chelating ligand 2 may allow for a coordination of a counter ion AuIIICl4- and reduction to 
AuICl with a concomitant C-S bond cleavage and loss of tert-butyl alcohol.  
2.2. Catalysis 
Oxidation is a very important method for the synthesis of chemical intermediates in the manufacture 
of high-tonnage commodities, high-value fine chemicals, agrochemicals and pharmaceuticals. 
Oxidation of olefins provides a way to turn mineral oil into chemicals of commercial value. Gold has 
been reported to be a catalyst in homogeneous and heterogeneous [24] oxidation reactions. The 
number of reports on truly homogeneous catalytic oxidation reactions with gold compounds is more 
limited. AuCl in combination with nitrogen or phosphorous containing ligands has been used as a 
catalyst in the aerobic oxidation of alcohols [25] and the oxidative cleavage of double [26], C-H, [27] 
and single and triple bonds [27]. Very importantly, AuIII cations have been used in the oxidation of 
methane to methanol (in the presence of strong acids) [28,29] while AuIII-chlorides and 




[AuCl2(NO3)(thioether)] complexes have been employed in sulfoxide [30,31] and thioether oxidations 
[32,33]. Common complexes such as Na[AuCl4] or [AuCl(PPh3)] have been used in the oxidation of 
alkanes (with very poor conversions) [34]. AuCl3 and AuCl2 with NO ligands have been used in the 
epoxidation of alkenes [35] and [Au(OAc)3] in the aerobic oxidation of dibenzylamine [36]. Very 
recently, oxidative transformations of Au-C(sp2) bonds [37] have been reported. In these processes 
there was strong evidence for the existence of AuI/AuIII catalytic cycles. This has opened up a new area 
of gold catalysis where in situ-generated Au-C(sp2) bonds can be oxidatively transformed in the 
presence of external oxidants [37].  
We wanted to study the catalytic activity of the new AuIII and AuI complexes with the same set of 
ligands BITOMe,StBu (2) [10] and chlorides. We chose the reaction depicted in Table 2: the oxidative 
cleavage of diphenyl ethylene in the presence of catalyst and tert-butyl hydroperoxide to produce 
benzophenone.  
Table 2. Oxidative Cleavage of Diphenyl Ethylene. 
 




Conversion % a 
1 3 Toluene / Acetonitrile 90 5 26  
2 3 Toluene / Acetonitrile 90 10 31  
3 4 Toluene RT 5 0 
4 4 Toluene RT 10 0 
5 4 Toluene 90 5 43 
6 4 Toluene 90 10 60 
7 5 Toluene / Acetonitrile 90 5 42 
8 5 Toluene / Acetonitrile 90 10 48 
9 6 Toluene / Acetonitrile 90 5 42 
10 6 Toluene / Acetonitrile 90 10 80 
11 7 Toluene / Acetone 90 5 0 
12 7 Toluene / Acetone 90 10 7 
13 9 Toluene 90 10 10 
a By 1H-NMR. 
AuCl in the presence of neocuproine (5 mol %) in different solvents catalyzed the reaction at 90 °C 
in 10 hours. The reaction could be run in water and the amount of catalyst and ligand could be 
decreased to 1 mol %. The replacement for AuCl3 salts afforded a very low conversion to 
benzophenone [26]. In our case, we tested the AuIII and AuI compounds 3 and 4 (entries 1-6) in either 
toluene or mixtures of toluene/acetonitrile for the cationic AuIII compound 3. The compounds were 
active although the conversions were lower than those described for AuCl and neocuproine. The AuI 
complex was a better catalyst than the AuIII derivative as previously described [26]. The increase of the 
amount of catalyst improved the conversion but did not double it. Our reaction time was higher (24 h 
instead of 10 h) and the reactions were run at 90 °C. We also tested the silver derivatives 5 and 6 and 
found a similar activity to the AuI for the one with covalent triflate (5) whereas the cationic silver 




derivative with PF6- anion (6) was the most active of all studied with a conversion of 80% (10 mol % 
cat). Homogeneous oxidation of organic products with silver derivatives is limited to a couple of not 
very detailed patents with inorganic silver salts (like AgNO3) [38,39]. To our knowledge, these are the 
first examples of well-defined organic soluble silver catalysts in oxidation reactions. In contrast, 
neither the CuI or CuII derivatives showed activity in this oxidative cleavage with TBHP. CuI 
complexes of 2 had been described as having a lower reactivity towards oxygen in comparison to other 
BIT ligands [11]. 
2.3. Biological Activity 
2.3.1. Antimicrobial Activity 
The antimicrobial activity of the new compounds 3-5, 7 as well as that of compound 9 and the 
ligand 2 were evaluated against yeast (Saccharomyces cerevisiae) Gram-negative (Escherichia coli 
and Salmonella tiphymurium) and Gram-positive (Bacillus cereus and Staphyloccocus aureus) bacteria 
(Table 3).  
The ligand {BITOMe,StBu} 2 was totally inactive against S. cerevisiae and the representative  
Gram-positive and Gram-negative bacteria. S. cerevisiae showed clearing at the highest concentration 
tested for gold and silver compounds, but was unresponsive towards the copper compounds; these 
compounds should be tested against fungi and other microbes to determine general toxicity ranges for 
eukaryotes. AuIII complex 3 showed moderate toxicity toward both Gram-positive bacteria, but had 
low toxicity towards the Gram-negative bacteria. Though AuI complex 4 showed low toxicity towards 
most bacteria, Escherichia coli was highly vulnerable to this compound, which may be a precursor for 
an narrow-range antibacterial. AgI complex 5 was highly toxic to all bacteria tested and is a promising 
candidate for a broad-range antibacterial. CuII complex 7 was highly toxic to Bacillus cereus, but 
completely innocuous to other bacteria, implying that a targeted antibacterial can be developed from 
compound 7. CuI complex 9 was not toxic to the bacteria tested in this study. 
Table 3. Toxicity assesment of compounds 3-5, 7, 9 and ligand 2 against microbial organisms.a 
Compound 
Yeast Gram-negative Gram-positive 
S. Cerevisiae 
(X2180-1A) E. Coli S. Tiphymurium B. Cereus S. Aureus 
2 b --- --- --- --- --- 
3 (AuIII) c 100 100 100 10 10 
4 (AuI) c 100 0.1 100 --- 100 
5 (AgI) c 100 10 10 10 10 
7 (CuII) c --- --- --- 10 --- 
9 (CuI) c --- --- --- --- --- 
a Minimun number of μg required to create a zone of clearing of 0.5 cm diameter on a lawn of 
fungal or bacterial cells: 1, 10, 100 or --- no toxicity. b Ligand 2 was dissolved in CH2Cl2. c Metallic 
compounds dissolved in CH3CN. 
We found that the silver derivative 5 is the most potent against Gram-negative bacteria with the 
exception of a lower toxicity for the AuI species towards the Gram-negative Escherichia coli bacteria. 
AuIII and AgI derivatives are more toxic towards Gram-positive bacteria than the AuI analogue. This in 




contrast to results found for AuI complexes containing phosphanes, including our work with AuI water-
soluble phosphanes [40]. The fact that gold compounds are more toxic for Gram-positive bacteria than 
Gram-negative ones or fungi has been noted previously with auranofin [41] and some other AuI 
phosphane derivatives [40,42] and N-heterocyclic carbene-AuI derivatives [43]. Compound 3 is one of 
the very few examples of AuIII derivatives exhibiting antimicrobial properties [44]. Dinuclear  
AgI-oxygen bonding complexes derived from camphanic acic ligands have displayed a wide spectrum 
of effective antimicrobial activity [45]. Some N-heterocyclic carbene AgI complexes inhibit more 
efficiently the growth of Gram-positive bateria including B. subtilis [46-48], Gram-negative E. coli 
[47-50], and P. aeruginosa [47,49,50] and even antibiotic resistant strains of S. aureus. [50,51] 
Binuclear and polymeric AgI complexes with a tridentate heterocyclic N- and S- ligand 8-(9pyridin-3-
yl)methylthio) quinoline were good inhibitors of Gram-positive bacteria and some Gram-negative 
bacteria (P. aeruginosa) but they were very poor against E. coli [52]. The behaviour of the silver 
compound 5 is similar to that of silver-carbene derivatives, [46-51] silver fluorinated tris(pyrazolyl)-
borate complexes [53] and AgNO3 and silver(I) sulfadiazine [52] inhibiting grow of both Gram-
negative and Gram-positive bacteria. However in the case of the tris(pyrazolyl)borate complexes it was 
demonstrated that the effect on Gram-positive species was due to the ligand whereas the activity for 
Gram-negative species was truly due to the silver ion [53]. In our case it seems that the activity 
displayed is due to the presence of the metal. Thus 5 has potential applications in the broad spectrum 
of antimicrobial field. 
2.3.2. Cytotoxicity 
The cytotoxic properties of the AuIII, AuI, AgI, CuII and CuI compounds were analyzed in vitro as 
previously described utilizing human HeLa cervical carcinoma cell line that expresses the Green 
Fluorescence Protein (GFP) in the nucleus [54,55]. Before use, all test compounds were dissolved in 
DMSO and used at a final solvent concentration of 0.1% that has no discernible effect on cell viability. 
The well known anticancer cytotoxic agent, cisplatin, was used as a positive control for cell death 
induction. It is apparent that the complexes displayed low to very low cytotoxicity towards HeLa cells. 
Gold compounds 3, 4 were 1/10 as effective as cisplatin in causing death of HeLa cells, whereas AgI 
(5) was 1/5 as effective. The cytotoxicity of 6 could not be evaluated due to the formation of crystals in 
the culture media. Due to the low solubility of the copper compounds 7, 9 in DMSO-H2O, their 
toxicity towards HeLa cells was very low (less than 10%) and could not be fully evaluated. If the 
values obtained are an indication of their cytotoxic potential at higher concentrations they would still 
fall far below the toxicity values of the other compounds and cisplatin. 
Moreover, we studied the cytotoxicity of compounds 3-5,7 and 9 against normal primary cells  
(Figure 2). Cytotoxicity was monitored by using live-cell imaging of a normal primary culture of 
adherent cells obtained from C57B6 mouse muscle explants after 22 hrs of incubation with the 
compounds. The cytotoxicity of these compounds against the normal cells was very low although there 
were some differences since complexes of AuI 4 and CuI (9) were slightly more toxic than the AuIII (3), 
AgI (5) and CuII (7) derivatives.  




Figure 2. In vitro cytotoxicity of compounds 3-5, 7 and 9 against normal cells (conc. μM). 
Cytotoxicity was monitored by using live-cell imaging of a normal primary culture of 
adherent cells obtained from C57B6 mouse muscle explants after 22 hrs of incubation with 
the compounds. Each bar represents average value of three measurements and error bars 
represent standard deviations. Results for compound 3 at 200 µM are not shown since there 
was no cytotoxicity observed. Three controls were included; untreated cells (Unt), treated 
with 0.5% v/v diluent of the chemical compounds (DMSO) and treated with 1 mM H2O2. 
 
This lack of toxicity in cancerous and normal mammalian cell lines makes them promising 
candidates as potential antimicrobial agents (low toxicity in human tissues) and as safer and  
greener catalysts.  
Table 4. IC50 values for HeLa-GPF cells of compounds 3-7 and ligand 2 [10] and complex 
9 [10], compared to cisplatin. 
 IC50(μM) a 
Cell line Cisplatin 2 b 3 4 5 6 b 7c 9 c 
HeLa-GPF 14.9 ---- 155 155 73.6 --- --- --- 
a IC50 is defined as the concentration of drug required to disrupt the plasma membrane of 50% of cell 
population, compared to untreated cells, after 22 hours of incubation. Cells with compromised plasma 
membrane were monitored using propidium iodide (PI) and flow cytometry. Cisplatin was used as reference 
compound. b Compound 6 was found to be soluble in DMSO but when 1 µL was added to culture media with 
cells the compound came out of solution forming crystals. Since it was difficult to evaluate how much of the 
compound was actually in solution, an accurate IC50 value could not be determined. In the case of compound 
2, it was possible to examine its cytotoxicity against HeLa-GFP cells at 250 µM, but its cytotoxicity was very 
poor (5.4 ± 2.1%). c Due to the low solubility of the copper compounds in the DMSO-H2O mixture, the 
maximum concentration possible tested for 7 and 9 was 50 and 25µM, and their percent of cytotoxicity was 
7.4 and 9, respectively. 
 
 






Solvents were purified by use of a PureSolv purification unit from Innovative Technology, Inc. 
(Newburyport, MA, USA); all other chemicals were used as received. Elemental analyses were carried 
out by Atlantic Microlab, Inc. (Norcross, GA, USA). Infrared spectra (4000-400 cm−1) were recorded 
on a Nicolet 380 FT-IR infrared spectrophotometer on KBr pellets. The 1H-, and 13C{1H}-NMR 
spectra were recorded in CDCl3 solutions at 25 °C on a Bruker 400 and spectrometer (δ, ppm; J, Hz); 
1H and 13C{1H} were referenced using the solvent signal as internal standard. EPR studies were 
conducted on a Bruker E500 EPR spectrometer. The mass spectra (ESI) were recorded from CH2Cl2 or 
CH3CN solutions by the mass spectrometry facility of the University of California Riverside 
(Riverside, CA, USA). X-ray data were collected with a Nonius Kappa CCD (Hunter College, The 
City University of New York, New York, NY, USA). Conductivity was measured in an Oakton 
pH/conductivity meter. Ligand 2 was prepared as previously reported [10], but we isolated and 
characterized precursor ligand BITOH,StBu (1) and prepared 2 from isolated 1. All other chemicals and 
solvents were purchased from Sigma-Aldrich and Strem Chemicals.  
1-Methoxy-2-methyl-1,1-bis(N-methyl-4,5-diphenyl-2-imidazolyl)2-tert-butylthiopropanol (1, BITOH,StBu). 
To a solution of N-methyl-4,5-diphenylimidazole (1.40 g, 6.0 mmol) in 30 mL of dry THF under N2 
cooled to −78 °C was added n-BuLi dropwise (2.5 M, 2.40 mL, 6.0 mmol). The mixture was stirred at  
−78 °C for 3 h to give a red-brown solution. After the addition of ethyl-2-methyl-tert-butylthio-
propanonate (0.41 g, 3.0 mmol), the mixture was allow to warm to room temperature overnight to give 
a yellow solution. The reaction was quenched with 80 mL of water and extracted with diethyl ether (20 
mL) three times. The organic phase was dried over MgSO4, filtered through Celite, and vacuum dried 
to give 1 as a pure white compound. Yield: 1.40 g, 75%. Anal. Calc. for C40H42N4OS (626.92): C, 
75.71; H, 6.88; N, 8.80; S, 4.78; found: C, 75.74; H, 6.68; N, 8.76; S, 4.54. MS (ESI+) [m/z]: 627.3 
[M+1]+. IR (cm−1): ν (C=N, C3N2) = 2958, ν (C-N, C3N2) = 1501, ν (C-OCH3) = 1074, ν (S-C (CH3)2) 
= 970. 1H-NMR: δ = 7.18−7.68 (m, 20H, Hp+Ho+Hm, C6H5 Bz); 5.70 (s, 1H, OH); 3.08 (s, 6H,  
N-CH3); 2.28 (s, 6H, SC (CH3)2); 1.49 (s, 9H, C (CH3)3). 13C{1H}-NMR: δ = 15.24 [C(CH3)3], 27.59 
(N-CH3), 32.05 [SC(CH3)2], 33.46 [C(CH3)3], 47.28 [SC(CH3)2], 59.73 (O-CH3), 126.17 (C3, C3N2), 
126.50 (C2, C3N2), 128.04 (Co, Ph), 128.08 (Cp, Ph) 131.07 (Cm, Ph), 134.67 (C1, Ph), 146.25  
(C1, C3N2). 
1-Methoxy-2-methyl-1,1-bis(N-methyl-4,5-diphenyl-2-imidazolyl)2-tert-butylthiopropane (2, BITOH,StBu) 
[10] can be prepared from isolated 1 in 80% yield as follows: to a suspension of sodium hydride  
(0.048 g, 1.92 mmol) in 10 mL of dry THF under N2 was added the solution of 1 (1.003 g, 1.6 mmol) 
in 10 mL of dry THF, and the resulting mixture was stirred for 1 h at room temperature. Methyl iodide 
(0.12 mL, 1.92 mmol) was added dropwise, and then the reaction mixture was stirred at reflux under 
N2 for 22 h. The reaction mixture was quenched with 80 mL of water and extracted with 
dichloromethane (20 mL) three times. The organic phase was dried over MgSO4, filtered through 
celite, and vacuum dried to give 2 as a yellow powder. Yield: 0.870 g, 80%. 




[Au{BITOMe,StBu}Cl][AuCl4]2 (3): To a solution of K[AuCl4] (0.166 g, 0.44 mmol) in acetonitrile  
(2 mL) a solution of BITOMe,StBu (2, 0.140 g, 0.22 mmol) in CH2Cl2 (20 mL) was added dropwise at  
0 °C. The resulting solution was allowed to stir for over 40 min at RT and the solvent was removed 
under vacuum to ca. 1 mL. Addition of Et2O/n-hexane (1:1,15 mL) and cooling to –5 °C afforded 3 as 
a pale orange solid that was filtered and dried under vacuum. Yield: 0.213 g, 62%. Anal. Calc. for 
C41H44N4OSAu3Cl9 (1550.85): C, 31.75; H, 3.61; N, 2.07; found: C, 32.04; H, 3.17; N, 3.69; MS 
(ESI+) [m/z]: 641.3 [Ligand -H]+. IR (cm−1): ν(C = N, C3N2) = 2958, ν(C-N, C3N2) = 1505, ν(C-OCH3) 
= 1090, ν[S-C(CH3)2] = 973. 1H-NMR: 7.18-7.54 (m, 20H, Hp+Ho+Hm, C6H5 Ph); 3.78 (s, 3H, O-CH3) 
3.47(s, 3H, N-CH3); 2.76 (s, 3H, N-CH3); 1.65 [s, 6H, SC (CH3)2]; 1.28 [s, 9H, C (CH3)3]. 13C{1H}- 
NMR: δ = 24.37 [C(CH3)3], 28.12 (N-CH3), 29.53 [SC(CH3)2], 33.51 [C(CH3)3], 36.44 [SC(CH3)2], 
45.80 (COCH3), 93.27 (COCH3), 126.70 (C3, C3N2), 127.99 (C2, C3N2), 128.94 (Cp, Ph), 129.45 (d, 
Cm, Ph) 129.82 (Co, Ph), 130.53 (C- C3N2, Ph), 173.73 (C1, C3N2). Λ(CH3CN) = 321 Ω–1cm2mol–1, 3 ions 
(1+/2-).  
[Au{BITOMe,StBu}Cl] (4): To a solution of [AuCl(tht)] (0.032 g, 0.10 mmol) in CH2Cl2 (10 mL) a 
solution of BITOMe,StBu (2, 0.064 g, 0.10 mmol) in CH2Cl2 (10 mL) was added dropwise at 0 °C. The 
resulting solution was allowed to stir for over 40 min at RT and the solvent was removed under 
vacuum to ca. 1 mL. Addition of Et2O/n-hexane (1:1, 15 mL) and cooling to –5 °C afforded 4 as a 
white solid that was filtered and dried under vacuum. Yield: 0.045 g, 69%. Anal. Calc. for 
C41H44N4OSAuCl (873.30): C, 56.39; H, 5.08; N, 6.42; found: C, 56.78; H, 5.16; N, 6.50; MS (ESI+) 
[m/z]: 873 [M + 1]. IR (cm–1): ν(C=N, C3N2) = 2954, ν(C-N, C3N2) = 1501, ν(C-OCH3) = 1087, ν [S-
C(CH3)2] = 960. 1H-NMR: δ =7.18-7.54 (m, 20H); 3.75 (s, 3H); 3.75 (s, 3H); 3.41 (s, 6H); 1.65 (s, 6H) 
1.34 (s. 9H). 13C{1H}-NMR: δ = 23.69 [C(CH3)3], 27.62 (N-CH3), 28.02 [SC(CH3)2], 33.46 [C(CH3)3], 
47.41 [SC(CH3)2], 55.05 (COCH3), 88.37 (COCH3), 125.73 (C3, C3N2), 126.56 (C2, C3N2), 127.94  
(Co, Ph), 128.96 (Cm, Ph), 130.53 (Cp, Ph), 138.27 (C1, C3N2). Λ(CH3CN) = 17 Ω–1cm2mol–1, neutral. 
[Ag{BITOMe,StBu}X] (X = OSO2CF3- 5, PF6- 6): To a solution of AgOSO2CF3 (0.026 g, 0.1 mmol, 5) or 
AgPF6 (0.075 g, 0.3 mmol, 6) in Et2O or CH3CN (5 mL) a solution of BITOMe,StBu (2) (0.064 g,  
0.10 mmol, 5 or 0.192 g, 0.3 mmol, 6) in CH2Cl2 (10 mL) was added dropwise at 0 °C. The resulting 
mixtures were allowed to stir for over 40 min at 0 °C protected from light exposure. Subsequent 
removal of the solvent under vacuum to ca. 1 mL, addition of Et2O/n-hexane (1:1, 15 mL) and cooling 
to –5 °C afforded 5 and 6 as a white solids that were filtered and dried under vacuum. Compound 5: 
yield: 0.050 g, 56%. Anal. Calc. for C42H44N4OS2AgF3 (897.81): C, 56.57; H, 4.29; N, 6.28; S, 7.19 
found: C, 56.13; H, 4.67; N, 5.93; S, 7.29. MS (ESI+) [m/z]: 748.22 [M]+. IR (cm–1): ν(C = N, C3N2) = 
2953, ν(C-N, C3N2) = 1505, ν(SO) = 1248 (br, s), 1157 (s), 1023 (m), ν(S-CF3) = 640 (signals of  
C-OCH3 and S-C(CH3)2 have been overlapped by the signals of covalent OSO2CF3). 1H-NMR: δ = 
7.23−7.74 (m, 20H, Hp+Ho+Hm, C6H5 Ph); 4.24 (t, 6H, N-CH3); 1.36 [s, 6H, SC(CH3)2]; 0.99 [s, 9H, 
C(CH3)3]. 13C{1H}-NMR: δ =14.06 [C(CH3)3], 25.36 (N-CH3), 28.18 [SC(CH3)2], 33.48 [C(CH3)3], 
35.79 [SC(CH3)2], 57.05 (COCH3), 61.14 (COCH3), 126.59 (C3, C3N2), 127.92 (C2, C3N2), 128.93 (Co, 
Ph), 129.76 (Cm, Ph), 131.12 (Cp, Ph), 132.81(C1, C3N2). Λ(CH3CN) = 93 Ω–1cm2mol–1, neutral. 
Compound 6: yield: 0.153 g, 60%. Anal. Calc. for C43H47N5SOAgPF6 (934.77): C, 55.25; H, 5.07; N, 
7.49; found: C, 55.01; H, 4.90; N, 7.04. MS(ESI+) [m/z]: 747.22 [M -1]+. IR (cm-1):  




ν(C=N, C3N2) =2958, ν(C-N, C3N2) = 1501, ν(C-OCH3) = 1074, ν(S-C(CH3)2) = 979. 1H-NMR: δ = 
7.58-7.27 (m, 20H, Hp+Ho+Hm, C6H5 Ph); 3.95 (s, 3H, N-CH3); 3.05 (br, 3H, O-CH3); 2.62 (s, 3H, N-
CH3); 1.64 [s, 6H, SC (CH3)2]. 13C{1H}-NMR: δ =14.07 [C(CH3)3], 22.62 (N-CH3), 31.21 [SC(CH3)2], 
33.51 [C(CH3)3], 35.67 [SC(CH3)2], 51.69 (COCH3), 82.58 (COCH3), 126.41 (C3, C3N2), 128.09 (C2, 
C3N2), 128.70 (Co, Ph), 129.40 (Cm, Ph), 131.39 (Cp, Ph), 144.16 (C1, C3N2). 31P{1H}-NMR (CDCl3):  
–144.32 (sept). Λ(CH3CN) = 220 Ω–1cm2mol–1, 2 ions (1+/1-). 
[Cu{BITOMe,StBu}Cl2] (7): To a solution of CuCl2 (0.0134 g, 0.10 mmol) in CH3CN (2 mL) a solution of 
BITOMe,StBu (2) (0.064 g, 0.10 mmol) in CH2Cl2 (10 mL) was added dropwise. The resulting yellow-
green solution was allowed to stir for over 1.5 h at RT and the solvent was removed under vacuum to 
ca. 1 mL. Addition of Et2O/n-hexane (1:1, 15 mL) afforded 7 as a green solid that was filtered and 
dried under vacuum. Yield: 0.049 g, 63%. Anal. Calc. for C41H44N4OSCuCl2.2H2O (811.38): C, 60.69; 
H, 5.96; N, 6.90; found: C, 60.67; H, 5.46; N, 6.92; MS(ESI+) [m/z]: 738 [M-Cl - 1]+. IR (cm−1): 
ν(C=N, C3N2) =2958, ν(C-N, C3N2) = 1501, ν(C-OCH3) = 1087, ν[S-C(CH3)2] = 976. Λ(CH3CN) =  
71.5 Ω–1cm2mol–1, neutral. 
3.2. Catalytic Experiments 
Typical procedure: To a solution of metallic complexes 3-7, 9 (amounts as specified in Table 2) in 
toluene (5 mL) or in toluene (3 mL) - acetonitrile (2 mL) or in toluene (3 mL) – acetone (2 m), a 
solution of biphenyl ethylene (88 μL, 0.5 mmol) and TBHP (0.171 mL, 70% solution in t-BuOH,  
1.2 mmol) were added at room temperature. The reaction mixture was stirred at 90 °C for 24 h. The 
conversion of benzophenone was determined by 1H-NMR after work-up of the mixture and isolation of 
the crude product. 
3.3. Single-Crystal X-ray Diffraction Studies  
Crystals of 8 (red prisms) where obtained when a solution of 3 in CH2Cl2 was crystallized by slow 
diffusion of Et2O at 0 °C. The intensity data for 8 were measured with a Bruker–Nonius Kappa CCD 
diffractometer (graphite monochromated Mo-Kα radiation, λ = 0.71073 Å, φ-ω scans) at 100(2) K 
(Table 1). The data were not corrected for absorption. Details of the solution and refinements for this 
compound are presented below: the crystal of 8, with approximate dimensions 0.36_0.06_0.02 mm, 
was orthorhombic with space group P212121. The final unit-cell constants of 8 were a = 11.032(2) Å,  
b = 18.178(4) Å, c = 18.202(4) Å, V = 3650.2(13) Å3, Z = 4, ρ = 1.973 gcm–1, μ = 8.342 mm–1. The 
structure of 8 was solved with SHELXS-97 and refined by full-matrix least-squares on F2 with 
SHELXL-97. The hydrogen atoms were included in the structure-factor calculations, but their 
parameters were not refined. The final discrepancy indices for the 8373 reflections (θ _ 27.52°) were  
R = 0.0464 (calculated on F) and Rw = 0.0929 (calculated on F2) with 438 parameters varied. Tables 
of thermal parameters and observed and calculated structure factors (crystal structure of compound 8) 
have been deposited at the Cambridge Crystallographic Data Center. Any request for this material 
should quote a full literature citation and the reference number CCDC 784217 and may be obtained 
from The Director, CCDC, 12 Union Road, Cambridge CB2 1EZ, UK (Fax: +441233336033; E-Mail: 
deposit@ccdc.cam.ac.uk or www: http://ccdc.cam.ac.uk).  




3.4. EPR studies  
The electron paramagnetic resonance (EPR) spectra was measured on a Bruker E500 EPR 
spectrometer operating at X-band. In the experiment, an ER4122SHQE cavity was used. A solution of 
7 (1 mM) in CH3CN at 77 K was introduced in a standard EPR quartz tube (707-SQ from Wilmad) and 
was measured at 77 K using an immersion quartz Dewar. The microwave frequency was determined. 
The X-band conditions were as follows: 3320 G, 1.0 mW microwave power, 9.51 GHz microwave 
frecuency, 23dB attenuation, 77 K, 4.0 G modulation amplitude, 100 kHz modulation frequency,  
60 dB gain; 163 ms conversion time, 167 s sweep time. EPR data acquisition and manipulation were 
performed using XeprView software (Bruker). CuSO4 in 50% ethylene glycol was used as a standard 
for spin quantification by double integration of EPR signal intensities. The signal-to-noise ratio in EPR 
spectra was improved by signal averaging when necessary. 
3.5. Antimicrobial Assays 
The gold compounds were tested for microbial toxicity in a Kirby-Bauer disk diffusion assay. Metal 
compounds 3-7 and 9 were dissolved in acetonitrile and ligand 2 (insoluble in CH3CN) in CH2Cl2 to a 
concentration of 10 mg/mL and serially diluted in methanol by factors of 10 to create solutions ranging 
down to 0.1 mg/mL. A solution (10 μL) was aliquoted onto a paper filter disk (5 mm diameter × 1 mm 
thickness) that were then vacuum dried and stored at –20 °C prior to the experiment. For the assay, a 
cell suspension (100 μL) containing 3 × 107 cells/mL were spread uniformly on a Mueller-Hinton (MH 
for bacteria) or Yeast Extract (YPD for fungi) agar plate (100 mm × 15 mm). After spreading four 
paper disks impregnated with either 100, 10, 1, or 0.1 μg of a compound were placed on the agar 
surface with a solvent control in the center of the plate. The plates were incubated at either 30 °C 
(fungi) or 37 °C (bacteria) for 48 h and resulting zones of growth suppression were measured. 
3.6. Cytotoxicity Assays 
Adherent HeLa-GFP human cervical carcinoma cells (Kanda et al.) [56] were seeded, in a 24 well 
plate format, 100,000 cells/well using DMEM media (1 mL, HyClone, Logan, UT) supplemented with 
antibiotics and 10% heat-inactivated newborn calf serum (HyClone). After overnight incubation, to 
allow cell attachment, they were exposed for 22 h to several concentrations of chemical compounds. 
Floating cells were collected in a ice-cold tube and placed on ice, while attached cells were treated for 
15 min with 0.25% of trypsin solution (Invitrogen, Carlsbad, CA, USA), diluted in serum free  
DMEM, and incubated at 37 °C. Cells from each individual well, included both those harvested by 
trypsinization and those floating, were centrifuged at 1,400 rpm for 5 min at 4 °C The media was then 
removed and cells resuspended in staining solution (500 µL) containing propidium iodide (2 µg/mL) 
dissolved in FACS buffer (PBS, 0.5 mM EDTA, 2% heat inactivated fetal bovine serum, and 0.1% 
sodium azide), incubated in the dark at room temperature for 15 min and analyzed by flow cytometry, 
using a Cytomic FC 500 cytometer (Beckman-Coulter, Miami, FL, USA). The data were analyzed 
using CXP software (Beckman-Coulter). 
 




3.7. Cytotoxicity against normal primary culture cells 
Mouse muscle cultures were initiated using tissue explants [57] from healthy 8 to 10 weeks old 
C57B6 mice utilizing DMEM media supplemented with 10% fetal bovine serum and antibiotics (also 
referred as complete media). After approximately two weeks of culture, when abundant growth of cells 
had appeared from the explants, extensive washes with fresh media were performed to eliminate 
floating cells to selectively keep the adherent cells. The morphology of the adherent cells was mostly 
of fibroblastic nature (Figure 3). Adherent cells were collected by trypsinization, counted and seeded at 
a density of 10,000 cells per well in 200 µL of complete media using a 96 well plate format, incubated 
overnight to promote cell adherence, and incubated for 22 h in the presence of compounds. A mixture 
of two fluorescent dyes, Propidium iodide (PI; MP Biomedicals, Solon, OH, USA) and Hoechst 33342 
(Invitrogen, Eugene, OR, USA) at a final concentration of 1 µg/mL each was added to treated cells 1 h 
prior to image capture from each individual well utilizing a BD Pathway 855 Bioimager system (BD 
Biosciences Rockville, MD, USA) [58]. While Hoechst dye has the ability to easily cross cell 
membranes of healthy and dead cells and stains nuclear DNA, PI is only able to stain dead or dying 
cells with compromised plasma membranes. The fluorescence signal emitted from each individual 
fluorophore was captured in two separate channels, according with the dye emission requirements. To 
acquire adequate cell numbers of cells for statistical analyses, images from nine contiguous image 
fields (3X3 montages) were captured per well utilizing a 20x objective. Data analysis determining the 
percentage of death cells from each individual well was performed by using BD AttoVision™ v1.6.2 
software [58].  
4. Conclusions  
In conclusion, we have prepared new stable complexes of group 11 metals with the previously 
described tripodal bis(imidazole) thioether ligand (N-methyl-4,5-diphenyl-2-imidazolyl)2C(OMe) 
C(CH3)2S(tert-Bu) ({BITOMe,StBu}, 2) [10] which offers a pincer N2S donor atom set. The gold and, 
especially silver derivatives are active in the oxidative cleavage of diphenylethylene with TBHP at  
90 °C. The use of modified BIT ligands (for which it is known that oxygenation reactivity is much 
higher for CuI derivatives) [11] may provide more efficient catalysts for this and other homogeneous 
oxidation processes. The antimicrobial activity of the ligand 2 and the metal complexes has been 
evaluated against Gram-positive and Gram-negative bacteria and yeast. The new gold and silver 
compounds display moderate to high antibacterial activity which is not due to the free ligand. Gold and 
silver complexes are also potent against fungi. Moreover, silver compound 5 seems to hold potential 
applications in the broad spectrum of antimicrobial field. The fact that the compounds display very low 
or no cytotoxicity on HeLa Human cervical carcinoma cells and normal mammalian cells makes them 
promising candidates as potential antimicrobial agents (low toxicity in human tissues) and as safer and 
greener catalysts.  
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